CWS Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
CWS Financial Advisors's ABBV Position: Q3 2026 in Review
CWS Financial Advisors increased its AbbVie (ABBV) stake by 2% in Q3 2026, buying an estimated $22.6K and bringing the position to 4,475 shares worth $1.17M. The position accounts for 0.26% of the portfolio, ranked #57.
CWS Financial Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.25M in Q1 2025. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- CWS Financial Advisors held 4,475 shares of AbbVie worth $1.17M as of Q3 2026.
- CWS Financial Advisors bought 88 AbbVie shares in Q3 2026, an estimated $22.6K.
- AbbVie made up 0.26% of CWS Financial Advisors's portfolio in Q3 2026, its #57 holding.
- CWS Financial Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
- CWS Financial Advisors's AbbVie position peaked at $1.25M in Q1 2025.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on CWS Financial Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.